Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. More specifically, Evotec France is unique within Evotec since it includes all activities and expertise for preclinical R&D of small molecule drugs, primarily in the field of oncology and cardiovascular diseases and a team dedicated to translation to the clinic, directly interacting with University Cancer Institute of Toulouse, largest oncology focused hospital in Europe. Nathalie is the head of the in vitro biology department, including in vitro pharmacology and biologics labs. She is managing 7 team leaders and personally leads the most mature project focused on cancer metabolism.
Building 16 – C2203
195, route d’Espagne